The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD), a
leading cause of chronic liver disease, has increased worldwide along with the epidemics of …

Colorectal cancer (CRC) is one of the most prevalent cancers worldwide, ranking as the
third most malignant. The incidence of CRC has been increasing with time, and it is reported …

Lipidomic profiling has emerged as a powerful tool for the comprehensive characterization
of bacterial species, particularly in the context of clinical diagnostics. Utilizing matrix-assisted …

Metformin is the first-line oral medication for treating type 2 diabetes mellitus (T2DM). In the
current study, an untargeted lipidomic analytical approach was used to investigate the …

Background Metformin is a drug with a long history of providing benefits in diabetes
management and beyond. The mechanisms of action of metformin are complex, and …

Aims To investigate clusters of adipose tissue dysfunction, that is, with adipose tissue insulin
resistance (ADIPO‐IR) and large waist circumference (WC), identify a worse lipidomic profile …

ABSTRACT Introduction Diabetes Mellitus (DM) is a chronic heterogeneous metabolic
disorder characterized by hyperglycemia due to the destruction of insulin-producing …

Background Hypothyroidism is clinically characterized by a decrease in levels of the
circulating thyroid hormones namely thyroxine and triiodothyronine. The main treatment for …

Background: Type 2 diabetes mellitus (T2DM) often accompanies by diabetic kidney
disease (DKD). The occurrence and progression of T2DM and DKD are closely related to …